Your monthly Vonjo cost savings if eligible
If you are eligible for the Vonjo patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Vonjo through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Vonjo patient assistance program?
You could receive your Vonjo without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Vonjo patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Vonjo.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Vonjo patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Vonjo medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Vonjo coupon provider?
At NiceRx, we help eligible individuals access the Vonjo patient assistance program. This means that we are not a Vonjo coupon, a Vonjo discount card, or a Vonjo copay card provider. We do not offer any medication trial offers, or free Vonjo samples.
Can NiceRx help me get Vonjo cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Vonjo medication, or if you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Vonjo cost without insurance?
Vonjo costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Vonjo oral capsules 100 mg will typically cost around $20,500 for 120 capsules. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Vonjo cost with insurance?
The copay of Vonjo will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Vonjo?
Vonjo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by CTI BioPharma Corp. Vonjo is a JAK inhibitor used for the treatment of adults with medium or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 109 /L.
This indication is approved under accelerated approval based on spleen volume reduction. Continued approval may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
What doses of Vonjo are available?
Vonjo is available in capsule form, in the following doses: 100 mg.
Please read the full prescribing information and the labeling provided with your medication and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Vonjo active ingredients
Vonjo contains pacritinib as the active ingredient, an oral kinase inhibitor with activity against wild-type Janus-associated kinase 2 (JAK2).
Vonjo side effects
The most common side effects of Vonjo in clinical trials include:
- Thrombocytopenia (low platelet counts)
- Peripheral edema
In rare instances, Vonjo can cause more serious side effects. These can include:
- Diarrhea – manage significant diarrhea with antidiarrheals, dose reduction, or dose interruption
- Prolonged QT interval
- Major adverse cardiac events (MACE) – the risk may be increased in current/past smokers and patients with other cardiovascular risk factors
- Thrombosis, including deep venous thrombosis, pulmonary embolism, and arterial thrombosis
- Secondary malignancies and lymphoma may occur
- Risk of infection
Your doctor will assess the benefits of using Vonjo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Vonjo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Vonjo drug interactions
Vonjo can interact with other medications. These include:
- Moderate CYP3A4 inhibitors or inducers
- Azole antifungals – itraconazole, ketoconazole
- Rifamycins – rifabutin, rifampin
- St. John’s wort
- Drugs used to treat seizures – carbamazepine, phenobarbital, phenytoin
- Drugs that affect the heart rhythm (QT prolongation) – clarithromycin, posaconazole, ribociclib
This list is not exhaustive and other prescription drugs may interact with Vonjo.
You should not use Vonjo if you:
- Are allergic to the active ingredient pacritinib
- Are allergic to any of the other ingredients in Vonjo
- Have hepatic impairment
- Have renal impairment
Talk to your doctor before using Vonjo if you:
- Are taking any of the medications that could interact with Vonjo
- Smoke or were previously a smoker
- Have had any other cancers
- Have had a blood clot, heart attack, other heart problems, or stroke
- Have an infection
- Have diarrhea or commonly have loose stools
- Have nausea or vomiting
- Have active bleeding, have had severe bleeding, or plan to have surgery
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed – You should not breastfeed during treatment and for 2 weeks after your last dose
Vonjo is the trademark brand name for pacritinib manufactured by CTI BioPharma Corp. A generic version of pacritinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vonjo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.